Lyubov S. Dyatchina
Research Subjects
Lyubov S. Dyatchina has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Дятчина Любовь Сергеевна
ФГБОУ ВО «Северо-Западный государственный медицинский университет имени И.И.Мечникова» Министерства здравоохранения Российской Федерации
2 shared publications- Aleksey A. Bulguryan
North-Western State Medical University Named After I.I. Mechnikov
1 shared publication - Anastasia P. Zaitseva
Saint-Petersburg State Pediatric Medical University
1 shared publication - Anastasia Yu. Akhtaova
North-Western State Medical University Named After I.I. Mechnikov
1 shared publication - Anastasiia A. Abramenko
Institute of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
1 shared publication - Anna V. Semenova
North-Western State Medical University Named After I.I. Mechnikov
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (2) , 59-68
Features of the course of bronchial asthma in older adults
BACKGROUND: Bronchial asthma (BA) in older adults is a significant medical and social problem due to population aging, increasing comorbidity, and age-related changes in the immune and respiratory systems. Age-related lung function changes make diagnosis and disease control significantly more difficult. Current research lacks data on older adults with BA in the Russian Federation. AIM: To study the clinical features of bronchial asthma in older adults in real-world practice. METHODS: We conducted a multicenter, cross-sectional cohort study with multivariate cluster analysis of outpatient records of patients aged 65 years from three polyclinics in Saint Petersburg. RESULTS: Among 619 records, BA was found in 1.97% of older adults, but diagnosis was often delayed due to comorbidity and differential diagnostic complexity. The mean age at BA diagnosis was 60 years. A mixed phenotype predominated, with very few childhood-onset or purely allergic cases. Correlations were found between BA severity and the Charlson Comorbidity Index, obesity, glomerular filtration rate, eosinophilia, hyperglycemia, and the mean daily inhaled glucocorticosteroid dose. CONCLUSION: A personalized, interdisciplinary approach is needed for managing older adults with BA.
- 22 June 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (2) , 59-68
Open AccessFeatures of the course of bronchial asthma in older adults
BACKGROUND: Bronchial asthma (BA) in older adults is a significant medical and social problem due to population aging, increasing comorbidity, and age-related changes in the immune and respiratory systems. Age-related lung function changes make diagnosis and disease control significantly more difficult. Current research lacks data on older adults with BA in the Russian Federation. AIM: To study the clinical features of bronchial asthma in older adults in real-world practice. METHODS: We conducted a multicenter, cross-sectional cohort study with multivariate cluster analysis of outpatient records of patients aged 65 years from three polyclinics in Saint Petersburg. RESULTS: Among 619 records, BA was found in 1.97% of older adults, but diagnosis was often delayed due to comorbidity and differential diagnostic complexity. The mean age at BA diagnosis was 60 years. A mixed phenotype predominated, with very few childhood-onset or purely allergic cases. Correlations were found between BA severity and the Charlson Comorbidity Index, obesity, glomerular filtration rate, eosinophilia, hyperglycemia, and the mean daily inhaled glucocorticosteroid dose. CONCLUSION: A personalized, interdisciplinary approach is needed for managing older adults with BA.
- 18 June 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (5) , 493-500
Targeted therapy in older adults with Alzheimer disease: a review
One of the most pressing issues today is the somatic and mental health of older adults due to increasing life expectancy and expanding diagnostic capabilities for various diseases. Alzheimer disease has a significant impact on the quality of life of patients and their families and results in substantial economic and social consequences for society. Patients with Alzheimer disease require continuous care and support, which demands considerable resources from health care and social service systems. Moreover, Alzheimer disease leads to reduced work productivity and increased health care expenditures. This review analyzes foreign and Russian articles published in the past 5 years in Scopus, PubMed Central, the Cochrane Library, and BMJ Case Reports regarding targeted therapy for Alzheimer disease, one of the most common neurodegenerative disorders that reduce quality of life. This review considers the main principles of targeted therapy used in older adults with Alzheimer disease are considered, along with its advantages, limitations, and future perspectives for this therapeutic approach.
- 18 June 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (5) , 493-500
Targeted therapy in older adults with Alzheimer disease: a review
One of the most pressing issues today is the somatic and mental health of older adults due to increasing life expectancy and expanding diagnostic capabilities for various diseases. Alzheimer disease has a significant impact on the quality of life of patients and their families and results in substantial economic and social consequences for society. Patients with Alzheimer disease require continuous care and support, which demands considerable resources from health care and social service systems. Moreover, Alzheimer disease leads to reduced work productivity and increased health care expenditures. This review analyzes foreign and Russian articles published in the past 5 years in Scopus, PubMed Central, the Cochrane Library, and BMJ Case Reports regarding targeted therapy for Alzheimer disease, one of the most common neurodegenerative disorders that reduce quality of life. This review considers the main principles of targeted therapy used in older adults with Alzheimer disease are considered, along with its advantages, limitations, and future perspectives for this therapeutic approach.
- Open Access
- 20 November 2024
- Published by ECO-Vector LLC in Cardiac Arrhythmias
- Vol. 4 (3) , 5-14
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): what is new?
The article presents key approaches to the diagnosis and treatment of atrial fibrillation in light of the new 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery. The main changes made to the new recommendations are reflected. The innovative patient-oriented principle of atrial fibrillation treatment — AF-CARE is considered in detail. An analysis of the updated scale for assessing the risk of stroke and systemic embolism CHA2DS2-VA is given. The article provides definitions of clinical, subclinical, trigger-induced, newly diagnosed, paroxysmal, persistent and permanent forms of atrial fibrillation, algorithms for the treatment of different forms of atrial fibrillation based on the choice of drug therapy taking into account the left ventricular ejection fraction. Much attention is paid to screening and early detection of atrial fibrillation. The categories of patients for whom screening is advisable are determined. The importance of early diagnostics of atrial cardiomyopathy using atrial myocardial strain analysis is emphasized. The role of timely, guideline-based treatment of comorbid pathology such as chronic heart failure, diabetes mellitus, obesity, obstructive sleep apnea, arterial hypertension and others is emphasized in order to prevent atrial fibrillation and, if it occurs, to reduce relapses.
- 20 November 2024
- Published by ECO-Vector LLC in Cardiac Arrhythmias
- Vol. 4 (3) , 5-14
Open Access2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): what is new?
The article presents key approaches to the diagnosis and treatment of atrial fibrillation in light of the new 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery. The main changes made to the new recommendations are reflected. The innovative patient-oriented principle of atrial fibrillation treatment — AF-CARE is considered in detail. An analysis of the updated scale for assessing the risk of stroke and systemic embolism CHA2DS2-VA is given. The article provides definitions of clinical, subclinical, trigger-induced, newly diagnosed, paroxysmal, persistent and permanent forms of atrial fibrillation, algorithms for the treatment of different forms of atrial fibrillation based on the choice of drug therapy taking into account the left ventricular ejection fraction. Much attention is paid to screening and early detection of atrial fibrillation. The categories of patients for whom screening is advisable are determined. The importance of early diagnostics of atrial cardiomyopathy using atrial myocardial strain analysis is emphasized. The role of timely, guideline-based treatment of comorbid pathology such as chronic heart failure, diabetes mellitus, obesity, obstructive sleep apnea, arterial hypertension and others is emphasized in order to prevent atrial fibrillation and, if it occurs, to reduce relapses.